703 filings
8-K
LADX
LadRx Corp
6 Jun 24
LadRx and ImmunityBio Mutually Agree to Terminate Aldoxorubicin License
6:03am
10-Q
2024 Q1
LADX
LadRx Corp
Quarterly report
15 May 24
6:22am
10-K
2023 FY
LADX
LadRx Corp
Annual report
27 Mar 24
6:03am
10-Q
2023 Q3
LADX
LadRx Corp
Quarterly report
14 Nov 23
6:16am
8-K/A
LADX
LadRx Corp
12 Oct 23
Departure of Directors or Certain Officers
6:08am
8-K
3x4jd9kotkrlc xinp7
11 Sep 23
Material Modifications to Rights of Security Holders
6:11am
ARS
mcfx5 kxbsy55
28 Jul 23
Annual report to shareholders
4:05pm
8-K
pq0uhwwaqs5zp5s mj5
26 Jun 23
LadRx Completes Non-Dilutive Financing Transaction for up to $11 Million with XOMA Corporation
6:20am
8-K
x3egycgc91
11 May 23
LadRx Announces Reverse Stock Split
6:05am
8-K
bb6bko 0n
30 Dec 22
Departure of Directors or Certain Officers
4:05pm
8-K
xyokk9
23 Sep 22
Amendments to Articles of Incorporation or Bylaws
6:15am
D/A
a2c8df2yv2a6wrnrr
28 Jul 22
$18.24M in equity / options / securities to be acquired, sold $8.24M, 1 investor
4:06pm